154 related articles for article (PubMed ID: 14647137)
1. Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study.
Hartmann JT; Oechsle K; Quietzsch D; Wein A; Hofheinz RD; Honecker F; Nehls O; Köhne CH; Käfer G; Kanz L; Bokemeyer C
Br J Cancer; 2003 Dec; 89(11):2051-6. PubMed ID: 14647137
[TBL] [Abstract][Full Text] [Related]
2. Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer.
Hofheinz RD; Willer A; Weisser A; Gnad U; Saussele S; Kreil S; Hartmann JT; Hehlmann R; Hochhaus A
Br J Cancer; 2004 May; 90(10):1893-7. PubMed ID: 15138468
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Hartmann JT; Pintoffl JP; Al-Batran SE; Quietzsch D; Meisinger I; Horger M; Nehls O; Bokemeyer C; Königsrainer A; Jäger E; Kanz L
Onkologie; 2007 May; 30(5):235-40. PubMed ID: 17460417
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.
Comella P; Casaretti R; De Rosa V; Avallone A; Izzo F; Fiore F; Lapenta L; Comella G
Ann Oncol; 2002 Dec; 13(12):1874-81. PubMed ID: 12453855
[TBL] [Abstract][Full Text] [Related]
5. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
[TBL] [Abstract][Full Text] [Related]
6. Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group.
Comella P; Casaretti R; De Vita F; Avallone A; Orditura M; Petrillo A; Gravina A; Faranda A; Comis S; Comella G; Catalano G
Ann Oncol; 1999 Aug; 10(8):915-21. PubMed ID: 10509152
[TBL] [Abstract][Full Text] [Related]
7. Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial.
Gnad-Vogt SU; Hofheinz RD; Saussele S; Kreil S; Willer A; Willeke F; Pilz L; Hehlmann R; Hochhaus A
Anticancer Drugs; 2005 Apr; 16(4):435-40. PubMed ID: 15746580
[TBL] [Abstract][Full Text] [Related]
8. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma.
Caudry M; Bonnel C; Floquet A; Marsault C; Quétin P; Pujol J; Maton O; Dujols JP; Caudry Y; Skawinski P
Am J Clin Oncol; 1995 Apr; 18(2):118-25. PubMed ID: 7900703
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial.
Stec R; Bodnar L; Smoter M; Korniluk J; Kuchar A; Młot B; Szczylik C
Oncologist; 2014 Apr; 19(4):356-7. PubMed ID: 24682464
[TBL] [Abstract][Full Text] [Related]
12. Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group.
Comella P; Biglietto M; Casaretti R; De Lucia L; Avallone A; Maiorino L; Di Lullo L; De Cataldis G; Rivellini F; Comella G
Oncology; 2001; 60(2):127-33. PubMed ID: 11244327
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
Becouarn Y; Brunet R; Bussières E; Marée D
Oncology; 1988; 45(4):269-72. PubMed ID: 3133620
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer.
Leonard P; Seymour MT; James R; Hochhauser D; Ledermann JA
Br J Cancer; 2002 Nov; 87(11):1216-20. PubMed ID: 12439708
[TBL] [Abstract][Full Text] [Related]
16. Infusional 5-fluorouracil and mitomycin C: an effective regimen in the treatment of advanced gastric cancer.
Rudi J; Werle S; Bergtholdt D; Hofheinz RD
Onkologie; 2005 Mar; 28(3):128-32. PubMed ID: 15772462
[TBL] [Abstract][Full Text] [Related]
17. Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer.
Chester JD; Dent JT; Wilson G; Ride E; Seymour MT
Ann Oncol; 2000 Feb; 11(2):235-7. PubMed ID: 10761764
[TBL] [Abstract][Full Text] [Related]
18. Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Aranda E; Cervantes A; Carrato A; Fernández-Martos C; Antón-Torres A; Massutí T; Barneto I; García-Conde J; Barón JM; Díaz-Rubio E
Ann Oncol; 1996 Aug; 7(6):581-5. PubMed ID: 8879371
[TBL] [Abstract][Full Text] [Related]
19. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
20. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML
Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]